Published in Chemotherapy on January 01, 1991
Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol (2012) 1.49
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients. Ann Oncol (2010) 1.14
Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study. Neoplasma (2005) 0.94
Mouse mammary tumor virus production stimulated by hormones and polyamines in cells grown in semi-synthetic in vitro conditions. Int J Cancer (1977) 0.85
Expression of p43 in breast cancer tissue, correlation with prognostic parameters. Cancer Lett (1992) 0.85
Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis. Scand J Infect Dis (1997) 0.84
Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation. J Immunol (2000) 0.82
Resistance pattern of 2816 isolates isolated from 17631 blood cultures and etiology of bacteremia and fungemia in a single cancer institution. Acta Oncol (1997) 0.81
Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancer. Breast Cancer Res Treat (1992) 0.80
Funguria in cancer patients: analysis of risk factors, clinical presentation and outcome in 50 patients. Infection (1997) 0.80
[Effect of the chain length of oligonucleotides on interferon induction]. Naturwissenschaften (1969) 0.80
Risk factors, aetiology, therapy and outcome in 123 episodes of breakthrough bacteraemia and fungaemia during antimicrobial prophylaxis and therapy in cancer patients. J Med Microbiol (1997) 0.80
Immunosuppression with cyclophosphamide: effect on antibody plaque-forming spleen cells and on hemolytic antibodies production. Neoplasma (1972) 0.80
Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG). Med Oncol Tumor Pharmacother (1990) 0.80
Ciprofloxacin plus vancomycin versus ceftazidime plus gentamicin in the treatment of pneumonia in granulocytopenic patients with or without venous catheters. Short communication. Chemotherapy (1992) 0.80
Immunosuppression by breast cancer associated p43-effect of immunomodulators. Breast Cancer Res Treat (1996) 0.79
Adjuvant clodronate therapy in patients with locally advanced breast cancer--long term results of a double blind randomized trial. Slovak Clodronate Collaborative Group. Neoplasma (2000) 0.79
Continuous production of avian sarcoma virus B77 by rat tumour cells in tissue culture. Int J Cancer (1969) 0.79
Gemcitabine and carboplatin treatment in patients with relapsing ovarian cancer. Neoplasma (2009) 0.79
Intensive combination chemotherapy (TTL-I protocol) of large cell and immunoblastic lymphomas--long-term observation. Neoplasma (1992) 0.79
Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. Bratisl Lek Listy (1996) 0.79
Formaldehyde release characteristics from a Swedish floor finish. Bull Environ Contam Toxicol (1988) 0.78
Expression of p43 associated placental isoferritin (PLF) correlates inversely with cell growth in breast cancer cell lines MCF-7 and T47-D. Neoplasma (1993) 0.78
Therapy of P388 leukemia with benzaldehyde. Neoplasma (1988) 0.78
Downregulation of lymphocyte mitogenesis by breast cancer-associated p43. Cancer Lett (1994) 0.78
Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study. Neoplasma (2005) 0.78
Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO. Bone Marrow Transplant (1996) 0.78
Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study. Neoplasma (2007) 0.78
Mammalian tropism of B77(RBI) virus. Expression of virus genome in the hamster sarcoma cell clones. Neoplasma (1975) 0.77
Netilmicin plus ceftriaxone versus amikacin plus ceftriaxone in the treatment of infections in granulocytopenic patients. Chemotherapy (1992) 0.77
Human melanoma cell lines: morphology, growth, and alpha-mannosidase characteristics. Neoplasma (1982) 0.77
Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells. Biochem J (2001) 0.77
Role of natural prostaglandins in the control of murine mammary tumor virus expression. J Cancer Res Clin Oncol (1982) 0.77
Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. Int J Clin Pharmacol Res (1996) 0.77
[The dynamics of psychosocial burden development in breast cancer survivors: clinical success with psychosocial consequences]. Klin Onkol (2011) 0.76
The influence of N-(2-hydroxyethyl)-palmitamide on virus-induced sarcomas in chickens and Rauscher leukemia in mice. Neoplasma (1975) 0.76
Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study. Support Care Cancer (2005) 0.75
National cancer control programs and setting priorities. Cancer Detect Prev (1986) 0.75
[Various antibiotics in the monotherapy and combined therapy of infections in cancer patients. Retrospective study of 290 patients]. Cas Lek Cesk (1991) 0.75
[Relation between carbonic anhydrase IX serum level, hypoxia and radiation resistance of head and neck cancers]. Klin Onkol (2014) 0.75
Combined chemoimmunotherapy of L5178Y lymphoma. Neoplasma (1978) 0.75
[On water pollution of the Dolnoves reservoir of the water dam in Frysták]. Cesk Hyg (1965) 0.75
Immunosuppression with Cytembena: effect on antibody plaque-forming spleen cells and on hemolytic antibodies production. Neoplasma (1973) 0.75
Circulating tumour cells in breast cancer--review. Klin Onkol (2010) 0.75
[Effectiveness of cisplatin with continuous infusion of 5-fluorouracil in neoadjuvant chemotherapy of carcinoma of the oral cavity]. Bratisl Lek Listy (1992) 0.75
Release of virus infectious to chickens by RBI rat sarcoma in tissue culture and by its ascites form into the ascitic fluid. J Natl Cancer Inst (1968) 0.75
Ceftriaxone versus ceftazidime plus aminoglycoside therapy for infections in patients with neutropenia after cytotoxic chemotherapy. Short communication. Neoplasma (1993) 0.75
[Treatment of pseudoaneurysms with injection of thrombin]. Rozhl Chir (2002) 0.75
Alteration of SRBC immunogenicity by cytostatics (Ypenyl and Cytembena). Neoplasma (1973) 0.75
Toward control of tumour and virus growth by helical RNA. I. Effect of poly I:C on tumour transplantation resistance in animals bearing tumours of viral and non-viral origin. Neoplasma (1972) 0.75
Histocompatible leukocyte transfusion during granulocytopenia. Neoplasma (1971) 0.75
[Toxicity of cisplatin with continuous infusion of 5-fluorouracil in neoadjuvant chemotherapy of carcinoma of the oral cavity]. Bratisl Lek Listy (1989) 0.75
Activity of epirubicin and dibromodulcitol in advanced breast cancer. Results of the South-East European Oncology Group Study. Oncology (1988) 0.75
Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Pilot study phase I. Neoplasma (2005) 0.75
Organization of cancer care in Slovakia. Arch Geschwulstforsch (1989) 0.75
Candidosis, aspergillosis and zygomycosis in an oncology department. Mycoses (1993) 0.75
An unusual presentation of testicular cancer. Bratisl Lek Listy (2008) 0.75
[Peroral ciprofloxacin in the therapy of infections in oncology patients]. Cas Lek Cesk (1990) 0.75
Fluconazole in the treatment of mycotic oropharyngeal stomatitis and esophagitis in neutropenic cancer patients. Chemotherapy (1991) 0.75
The progress in the radiotherapy of rectal carcinomas. Bratisl Lek Listy (2009) 0.75
Blastic crisis of chronic myelogenous leukaemia. Neoplasma (1969) 0.75
High-dose chemotherapy and autologous peripheral stem cell transplantation in patients with relapsing malignant lymphomas--first experience in the Slovak Republic. Ann Oncol (1995) 0.75
Treatment of the blastic phase of chronic myeloid leukaemia. A question to solve. Haematologica (1972) 0.75
Immunosuppression with thyminalkylamine (Ypenyl Spofa): effect on antibody plaque-forming spleen cells. Neoplasma (1972) 0.75
[Use of hexachlorophene in the treatment and prevention of scabies]. Cesk Dermatol (1972) 0.75
Treatment strategy of the HER 2 positive breast cancer with CNS metastases. Bratisl Lek Listy (2009) 0.75
Fungal pathogens in etiology of septic shock in neutropenic patients with cancer (short communication). Zentralbl Bakteriol (1993) 0.75
Relevance of the Doppler flowmetry in the diagnosis of pathological alterations in the post-menopausal endometrium. Neoplasma (1999) 0.75
Analysis of radiation-induced angiosarcoma of the breast. Bratisl Lek Listy (2014) 0.75
The role of psychosocial oncology in the health care of breast cancer survivors. Bratisl Lek Listy (2009) 0.75
In vitro antiproliferative effect of interferon alpha in solid tumors: a potential predictive test. Neoplasma (1993) 0.75
Bacteremia due to Enterobacter spp. in cancer patients--analysis of 51 episodes. Int J Antimicrob Agents (1997) 0.75
Treatment of adult acute lymphoblastic leukemia: results of two trials. Neoplasma (1981) 0.75
Treatment of acute lymphoblastic leukemia in children. Long-term results of two trials. Neoplasma (1983) 0.75
Doppler flowmetry in the differentiation of biological characteristics of ovarian cancer. Neoplasma (1999) 0.75
Indication of pre-surgical radiochemotherapy enhances psychosocial morbidity among patients with resectable locally advanced rectal cancer. Neoplasma (2016) 0.75
Carboplatin and cyclophosphamide in the treatment of metastatic seminoma. Neoplasma (2000) 0.75
Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors. Neoplasma (2000) 0.75
Intralaryngeal pressure conditions and a membranophonic interpretation of voice production. Folia Phoniatr (Basel) (1993) 0.75
[Neo-adjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer treatment--a retrospective study]. Klin Onkol (2009) 0.75
Single versus combination chemotherapy of L1210 leukemia. Neoplasma (1980) 0.75
[Initial experience with fluconazole, a new triazole antimycotic agent, in oncology patients]. Cas Lek Cesk (1990) 0.75
Determination of suramin in clinical samples using HPLC. Neoplasma (1991) 0.75
Lack of correlation between the carcinostatic effect and the inhibition of glycolysis caused by tris-(beta-chlorethyl)-amine. Chemotherapy (1970) 0.75
Bacteremia and fungemia in cancer patients with venous catheters. Neoplasma (1995) 0.75
Effect of the pretreatment with some cytostatic agents on the growth rate of leukaemia L5178Y. Neoplasma (1974) 0.75
Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease. Neoplasma (1991) 0.75
[Chronic myelocytic leukemia. Is the insufficient treatment at the terminal stage a reason for changing therapeutical tactics of the chronic phase?]. Vnitr Lek (1974) 0.75
Induction of tumors in hamsters by rat Rous sarcoma RBI, producing chick sarcoma virus. I. Continuous production of virus oncogenic for chicks by hamster sarcoma cells. J Natl Cancer Inst (1970) 0.75
[Hygienic problems of the detergents. VI. The influence of synthetic detergents (washing and cleaning agents used in households) upon certain aquatic animals]. Cesk Hyg (1965) 0.75